NCT01019538

Brief Summary

The purpose of this study is to evaluate if supplemental oxygen during air travel can be reliably titrated using a Hypoxia-altitude simulation test (HAST). Also, the effect of oxygen supplementation given with the various oxygen equipment allowed for air travel is studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 25, 2009

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

July 6, 2011

Status Verified

November 1, 2009

Enrollment Period

1.3 years

First QC Date

November 23, 2009

Last Update Submit

July 3, 2011

Conditions

Keywords

OxygenHypoxemiaAir travel

Outcome Measures

Primary Outcomes (1)

  • PaO2 obtained from oxygen titration during HAST vs hypobaric chamber

    1 day

Interventions

The Hypoxia-altitude simulation test, which is established in clinical practice, is compared to the gold standard of hypobaric chamber while giving supplemental gaseous oxygen without and with oxygen conserving device, and with oxygen concentrator.

Also known as: Oxygen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

COPD patients

You may qualify if:

  • COPD patients who have performed a Hypoxia-altitude simulation test with a PaO2 \< 6.7 kPa

You may not qualify if:

  • exacerbation or pneumothorax within the previous six weeks
  • LTOT
  • anemia
  • pulmonary disease other than COPD
  • cerebrovascular or symptomatic cardiovascular disease
  • claustrophobia
  • inability to equalize pressure in the middle ear

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital Ullevaal, Department of Pulmonary Medicine

Oslo, Oslo County, 0407, Norway

Location

Related Publications (5)

  • Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984 Dec;130(6):980-6. doi: 10.1164/arrd.1984.130.6.980.

    PMID: 6508019BACKGROUND
  • Akero A, Christensen CC, Edvardsen A, Skjonsberg OH. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J. 2005 Apr;25(4):725-30. doi: 10.1183/09031936.05.00093104.

    PMID: 15802350BACKGROUND
  • Akero A, Christensen CC, Edvardsen A, Ryg M, Skjonsberg OH. Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease. Aviat Space Environ Med. 2008 May;79(5):518-24. doi: 10.3357/asem.2120.2008.

    PMID: 18500050BACKGROUND
  • Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest. 2008 Apr;133(4):1002-5. doi: 10.1378/chest.07-1354.

    PMID: 18398121BACKGROUND
  • Akero A, Edvardsen A, Christensen CC, Owe JO, Ryg M, Skjonsberg OH. COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen. Chest. 2011 Jul;140(1):84-90. doi: 10.1378/chest.10-0965. Epub 2010 Nov 11.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Arterial blood gases

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveHypoxia

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Officials

  • Ole H Skjønsberg, Prof.dr.med

    Oslo University Hospital

    STUDY DIRECTOR
  • Aina Akerø, M.D.

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 23, 2009

First Posted

November 25, 2009

Study Start

December 1, 2008

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

July 6, 2011

Record last verified: 2009-11

Locations